Nanofiltration of extracellular vesicles from human plasma & their on-chip qualification and quantification with a NanoBioAnalytical platform

作     者：Obeid Sameh Benoît Le Roy de Boiseaumarie Celine Elie-Caille Wilfrid Boireau Ming Li Chou Thierry Burnouf Pei-Shan Sung Shie-Liang Hsieh 

作者机构：Institut FEMTO-ST Univ. Bourgogne Franche Comté CNRS France Graduate Institute of Biomedical Material and Tissue Engineering College of Biomedical Engineering Taipei Medical University Taiwan International PhD Program in Biomedical Engineering College of Biomedical Engineering Taipei Medical University Taiwan Institute of Clinical Medicine National Yang Ming University Taipei Taiwan Genomic Research Center Academia Sinica Taiwan Department of Medical Research Taipei Veterans General Hospital Taiwan 

出 版 物：《Meta Gene》 

年 卷 期：2018年第17卷

页      面：S7-S7页

摘      要：One complication of plasma transfusion is non-immune transfusion related acute lung injury (TRALI), which is associated with the formation of neutrophil extracellular traps (NETs) resulting from polymorphonuclear neutrophil (PMN) activation. Activated platelets have recently been shown to trigger NETs formation. We hypothesized that (a) NETs could be promoted by platelet derived microparticles (PMPs) and (b) that 75 nm-nanofiltration of plasma, by removing parts of PMPs, could avoid NETs formation. To better characterize the large spectrum of size and concentration of PMPs in complex media, we combined conventional approaches (Flow Cytometry, TRPS) with an original nanobioanalytical (NBA) platform based on Surface Plasmon Resonance imaging (SPRi) and Atomic Force Microscopy (AFM) techniques. We will demonstrate that this new analytic solution allows: • a label-free follow-up of PMPs capture in real time from various complex media, • a multiplex detection of different PMPs subpopulations, • the determination of the size and morphology of captured PMPs in a range of 20 nm to 1 μm their proteomic studies. We expect that such platform will contribute to (i) a better understanding of the physiological function of Evs subpopulations, (ii) the discovery of specific biomarkers and (iii) to therapeutic follow-up.